![Eduardo Recoder de la Cuadra](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eduardo Recoder de la Cuadra
Directeur Général chez
FAES FARMA, S.A.
Fortune : 165 662 $ au 31/08/2026
Profil
Eduardo Recoder de la Cuadra is currently Chief Executive Officer at Faes Farma SA since 2024.
He is Director at SIFI SpA (since 2025), Tecnologia & Vitaminas SL (since 2024), Laboratório Edol – Produtos Farmacêuticos SA (since 2025), Ingaso Farm SL (since 2024), Faes Farma Chile Salud y Nutrición Ltda.
(since 2025), Capitolosedici SpA (since 2025), Faes Farma México SA de CV (since 2024), Faes Farma SAS (since 2024), Faes Farma del Ecuador SA (since 2024), Faes Farma Perú SAC (since 2024), Faes Farma Portugal, S.A. (since 2025), Setriworld – Promoção e Investimento, SA (since 2025).
He is also Principal at Lazlo International SA (since 2024) and SIFI France SASU (since 2025).
Formerly, he was Chairman at AstraZéneca Farmacéutica Spain SA from 2016 to 2020, Chairman at AstraZeneca do Brasil Ltda.
from 2012 to 2015, Chairman at AstraZeneca Produtos Farmacêuticos Lda.
from 2010 to 2012, Director-Primary Care Business Unit at AstraZéneca Farmacéutica Spain SA from 2007 to 2010, Director-Corporate Commercial at Grünenthal Pharma SA from 2003 to 2026, and Vice President-Western & Southern Europe at AstraZeneca AG from 2020 to 2024.
Education includes an undergraduate degree from the University of Barcelona and an MBA from the University of Navarra.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FAES FARMA, S.A. 0,01% | 31/12/2025 | 31 622 ( 0,01% ) | 165 662 $ | 31/08/2026 |
Postes actifs de Eduardo Recoder de la Cuadra
| Sociétés | Poste | Début |
|---|---|---|
| FAES FARMA, S.A. | Directeur Général | 01/09/2024 |
Faes Farma SAS | Directeur/Membre du Conseil | 01/11/2024 |
Capitolosedici SpA
 Capitolosedici SpA Financial ConglomeratesFinance Functions as an investment holding company | Directeur-Opérations de Back Office | 01/09/2025 |
SIFI SpA
 SIFI SpA Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and commercialization of therapeutic products for patients | Directeur/Membre du Conseil | 01/09/2025 |
Laboratorio Edol Produtos Farmaceuticos SA
 Laboratorio Edol Produtos Farmaceuticos SA Medical SpecialtiesHealth Technology Develops ophthalmology products | Directeur/Membre du Conseil | 01/06/2025 |
Faes Farma Chile Salud y Nutrición Ltda. | Directeur/Membre du Conseil | 01/01/2025 |
Faes Farma del Ecuador SA | Directeur/Membre du Conseil | 01/11/2024 |
Faes Farma Perú SAC | Directeur/Membre du Conseil | 01/11/2024 |
Anciens postes connus de Eduardo Recoder de la Cuadra
| Sociétés | Poste | Fin |
|---|---|---|
Grünenthal Pharma SA
 Grünenthal Pharma SA Pharmaceuticals: OtherHealth Technology Manufactures medicines | Corporate Officer/Principal | 01/01/2026 |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Eduardo Recoder de la Cuadra
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
34
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Faes Farma SA
 Faes Farma SA Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Barcelona
 University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Navarra
 University of Navarra Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZéneca Farmacéutica Spain SA
 AstraZéneca Farmacéutica Spain SA Pharmaceuticals: MajorHealth Technology Produces pharmaceutical products | Health Technology |
SIFI SpA
SIFI SpA Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing and commercialization of therapeutic products for patients | Health Technology |
AstraZeneca do Brasil Ltda. | |
Tecnologia & Vitaminas SL
 Tecnologia & Vitaminas SL Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
AstraZeneca Produtos Farmacêuticos Lda. | Distribution Services |
Laboratorio Edol Produtos Farmaceuticos SA
Laboratorio Edol Produtos Farmaceuticos SA Medical SpecialtiesHealth Technology Develops ophthalmology products | Health Technology |
Ingaso Farm SL
 Ingaso Farm SL Agricultural Commodities/MillingProcess Industries Engages in animal nutrition and feeding of pigs | Process Industries |
Astrazeneca AG | |
Grünenthal Pharma SA
Grünenthal Pharma SA Pharmaceuticals: OtherHealth Technology Manufactures medicines | Health Technology |
Faes Farma Chile Salud y Nutrición Ltda. | |
Capitolosedici SpA
Capitolosedici SpA Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Faes Farma México SA de CV | |
Faes Farma SAS | |
Faes Farma del Ecuador SA | |
Faes Farma Perú SAC | |
Lazlo International SA | |
SIFI France SASU
 SIFI France SASU Drugstore ChainsRetail Trade Retails pharmaceutical products | Retail Trade |
